Key facts
- This page summarizes Peter Lamb's Form 4 filing for EXELIXIS, INC. (EXEL).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 16 Dec 2022, 19:09.
Peter Lamb - 15 Dec 2022 Form 4 Insider Report for EXELIXIS, INC. (EXEL)
- Reporting relationship
- EVP, Scientific Strategy & CSO
- Issuer ticker
- EXEL
- Reported as of
- 15 Dec 2022
- Net transaction value
- -$233,600
- SEC form
- 4
- Accepted by SEC
- 16 Dec 2022, 19:09:47 UTC
- Prior SEC filing
- 17 Nov 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Nina Ayer, Attorney in Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Peter Lamb filed Form 4 for EXELIXIS, INC. (EXEL) on 16 Dec 2022.
Change
- Previous filing in this sequence was filed on 17 Nov 2022.
- Current net transaction value: -$233,600.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
EXEL
transaction
Common Stock
Options Exercise
- Transaction value
- $84,000
- Shares
- +20,000
- Change %
- +4.9%
- Price
- $4.20
- Shares after
- 430,958
- Date
- 15 Dec 2022
- Ownership
- Direct
- Footnotes
- F1
EXEL
transaction
Common Stock
Sale
- Transaction value
- $317,600
- Shares
- -20,000
- Change %
- -4.6%
- Price
- $15.88
- Shares after
- 410,958
- Date
- 15 Dec 2022
- Ownership
- Direct
- Footnotes
- F2, F3
EXEL
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 17,105
- Date
- 15 Dec 2022
- Ownership
- By 401(k)
- Footnotes
- F4
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
EXEL
transaction
Derivative
Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -20,000
- Change %
- -50%
- Price
- $0.000000
- Shares after
- 20,000
- Date
- 15 Dec 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 20,000
- Exercise price
- $4.20
- Footnotes
- F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
Includes 120,383 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
Footnote F2
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 10, 2022.
Footnote F3
Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $15.71 to $16.07. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4.
Footnote F4
Represents shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of December 14, 2022.
Footnote F5
The option, representing the right to purchase a total of 40,000 shares of Exelixis, Inc. common stock, became fully exercisable on February 11, 2020.